SFRP5 and type 2 diabetes mellitus: In the same study two independent mouse models of obesity exhibited reduced sFRP5 expressions and an increased wnt5a/sFRP5 ratio in adipose tissue [14] suggesting these two bioactive molecules to be involved in the development of obesity and type 2 diabetes.